What a MOTS-c before and after actually documents
It is worth being precise about what it is instead. A before and after is a record that something changed. It is not a record of why. Those two claims look identical on a phone screen and are separated by nearly everything that matters.
Take the caption away and three facts remain. A state at one moment. A state at a later moment. A person who decided to publish both. Everything else in the post, including the causal arrow, is supplied by the reader.
That is not an accusation of dishonesty. Most people posting these are describing their own experience accurately. The problem is structural rather than moral: the format has no place to put the other explanations, so they vanish, and the reader sees a clean line between a purchase and an outcome that the poster never had the means to draw either.
The weeks that are not in the frame
Someone who buys a research peptide aimed at metabolism is rarely doing only that. The decision usually arrives inside a broader effort. In the same eight weeks, the following commonly change at once: calorie intake, protein intake, alcohol, sleep timing, training volume, step count, work stress, and how carefully food is being measured. Any one of those moves a waist measurement or a fasting glucose reading on its own.
Two further effects are easy to miss. Lab values wobble. A fasting glucose or an insulin reading taken on two different mornings, after two different nights, will differ without anything having been done at all, which is why a single pair of panels can show a change that means nothing. And people who start something new tend to be at a low point when they start, so the second measurement is often taken from a temporary trough rather than a stable baseline.
Then there is what you never see. Nobody posts the pair of images where nothing happened. Nobody posts the panel that got worse. The visible set of before and after posts is filtered before it reaches you, and the filter selects for the outcome the reader is looking for.
What each kind of evidence can carry
The bottom row exists for one reason. A control group is the only device on the list that holds every other explanation still while the compound is the thing that varies. Everything above it is a description of what happened. Only the bottom row is a measurement of what the compound did.
| Evidence type | Subject | What it can show | What it cannot show |
|---|---|---|---|
| A pair of personal photographs | One human | That an appearance changed | Which of a dozen changes did it |
| A pair of lab panels | One human | That a number moved between two draws | Whether the move is real or ordinary variation |
| A run of posts across months | One human | Consistency of reporting | Anything about the people who stopped posting |
| A provider's collected cases | Humans, uncontrolled | What happened to people who chose the treatment | What would have happened without it |
| Published animal work | Mouse and cell culture | That a biological effect exists in that system | Whether it transfers to a human body |
| A randomised controlled trial | Humans, with a comparison group | The difference the compound itself makes | Nothing that matters here, which is the point |
The trial that would settle it, and why there is not one
There is no registered human trial of this compound. What exists is a record with the shape of one: NCT07505745, Phase 2, 120 participants, insulin sensitivity in adults with prediabetes and overweight or obesity, listed as recruiting. Its lead sponsor is Hudson Biotech, a name appearing on seven other records posted between February and April 2026, covering the other compounds this market sells. One of the seven says in its own brief summary that it is a fictional example of a ClinicalTrials.gov-style record.
That entry deserves exactly the scepticism this page has been applying to a photograph. It is a document somebody filed, formatted to look like evidence, and it persuades for the same reason a before and after persuades: it has the shape of the thing it is not. The check is duller than the claim. Open the record, read the lead sponsor and the brief summary, and see whether anybody is answerable for it.
What a real trial would have that a thousand posts do not is a comparison group, a defined population, a measurement chosen in advance, and a result reported whichever way it comes out. That last point is the one neither the internet nor an unattended registry entry can reproduce. The human evidence for this peptide is currently nothing at all. The real work is animal and cell culture, mostly in mice, which is a legitimate place for a compound to be and is not the same as an effect demonstrated in people.
What the regulated market puts in place of a photograph
A prescription medicine reaches a consumer with a claim attached that somebody had to earn. To put an indication on a label, a manufacturer has to show a regulator a controlled result, and the regulator gets to say no. The leaflet inside the box then lists the harms as well as the benefits, because a body of human data exists to list them from.
Outside that system there is no leaflet, no approved indication and no authority that has said no to anything. The evidence a consumer is offered instead is the before and after post, and it is worth seeing that substitution clearly. It is not a smaller version of the same thing. It is a different category of claim, produced by people with no obligation to publish the cases that went nowhere.
That is the trade being made. It may still be one somebody wants to make, and it should be made with the exchange rate in view.
The clinic version of the same format
Providers publish before and after material too, and it looks materially better. The photographs are taken in consistent lighting. The lab panels come from a named laboratory. There is a case number instead of a username, and sometimes a clinician's commentary explaining what changed.
Every one of those improvements is about the quality of the record. None of them is about the logic. A clinic gallery is still a collection of people who chose the treatment, whose outcomes were measured without a comparison group, and who were selected for publication by the party being paid. The presentation gets better and the missing piece stays exactly the same size.
There is a further wrinkle worth naming. A clinic sees only its own patients, so it also collects only its own successes and failures, and it has no obligation to display the second group. A pharmaceutical company reporting a trial does have that obligation, enforced by registration and by regulators who read the protocol before the study started. That difference in obligation, rather than any difference in honesty, is why one set of images is marketing and the other is evidence.
The service a clinician genuinely provides sits elsewhere. Screening for conditions that make the whole idea unwise, checking interactions with existing prescriptions, arranging baseline bloodwork so a later number can be interpreted at all. Those are worth paying for on their own terms, and none of them turns a paired image into a demonstrated effect.
A four question test for the next post you read
Ask what else changed in the same period, and assume the honest answer is several things.
Ask where the people are who had no result, and notice that you have no way of counting them.
Ask what the comparison is. Better than the state I was in when I felt bad enough to buy something is a comparison that flatters almost any purchase.
Ask what the poster stands to gain. A discount code under a MOTS-c before and after image is not proof of dishonesty, but it does tell you which outcome the post was selected for.